This inventor holds 1 USPTO granted patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andreas Wagner: Innovator in Pharmaceutical Compounds
Introduction
Andreas Wagner is a notable inventor based in Dottikon, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in developing methods for treating diseases related to mutant KIT and PDGFRA.
Latest Patents
Wagner holds a patent for "Synthetic methods and intermediates for producing compounds for treating KIT- and PDGFRA-mediated diseases." This patent provides methods and intermediates for making Compound A or a pharmaceutical salt thereof, which are useful in treating various diseases and conditions associated with mutant KIT and PDGFRA.
Career Highlights
Andreas Wagner is currently employed at Blueprint Medicines Corporation, where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for serious medical conditions.
Collaborations
Wagner collaborates with talented professionals in his field, including Gilles Caillot and Khalid Diker. Their combined expertise enhances the research and development efforts at Blueprint Medicines Corporation.
Conclusion
Andreas Wagner's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His work in developing treatments for KIT- and PDGFRA-mediated diseases is a testament to his impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile